-
1
-
-
34250656516
-
Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection
-
Gomez-Reino J, Carmona L, Descalzo M (2007) Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection. Arthritis Rheum 57:756-761
-
(2007)
Arthritis Rheum
, vol.57
, pp. 756-761
-
-
Gomez-Reino, J.1
Carmona, L.2
Descalzo, M.3
-
2
-
-
0033559125
-
Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection which is not compensated for by lymphotoxin
-
Bean AG, Roach DR, Briscoe H et al (1999) Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection which is not compensated for by lymphotoxin. J Immunol 162:3504-3511
-
(1999)
J Immunol
, vol.162
, pp. 3504-3511
-
-
Bean, A.G.1
Roach, D.R.2
Briscoe, H.3
-
3
-
-
0028979703
-
Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice
-
Flynn JL, Goldstein MM, Chan J et al (1995) Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 2:561-572
-
(1995)
Immunity
, vol.2
, pp. 561-572
-
-
Flynn, J.L.1
Goldstein, M.M.2
Chan, J.3
-
4
-
-
0035846326
-
Tuberculosis associated with infliximab, a tumor necrosis factor-α-neutralizing agent
-
Keane J (2001) Tuberculosis associated with infliximab, a tumor necrosis factor-α-neutralizing agent. N Engl J Med 345:1098-1104
-
(2001)
N Engl J Med
, vol.345
, pp. 1098-1104
-
-
Keane, J.1
-
5
-
-
33646269274
-
Does anti-tumour necrosis factor a treatment modify the tuberculin PPD response?
-
Joven BE, Almodovar R, Galindo M, Mateo I, Pablos JL (2006) Does anti-tumour necrosis factor a treatment modify the tuberculin PPD response? Ann Rheum Dis 65:699
-
(2006)
Ann Rheum Dis
, vol.65
, pp. 699
-
-
Joven, B.E.1
Almodovar, R.2
Galindo, M.3
Mateo, I.4
Pablos, J.L.5
-
6
-
-
0032902382
-
Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion
-
Menzies D (1999) Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion. Am J Respir Crit Care Med 159:15-21
-
(1999)
Am J Respir Crit Care Med
, vol.159
, pp. 15-21
-
-
Menzies, D.1
-
7
-
-
23944526078
-
Attenuated response to purified protein derivative in patients with rheumatoid arthritis: Study in a population with a high prevalence of tuberculosis
-
Ponce de Leon D, Acevedo-Vasquez E, Sanchez-Torres A et al (2005) Attenuated response to purified protein derivative in patients with rheumatoid arthritis: Study in a population with a high prevalence of tuberculosis. Ann Rheum Dis 64:1360-1361
-
(2005)
Ann Rheum Dis
, vol.64
, pp. 1360-1361
-
-
Ponce de Leon, D.1
Acevedo-Vasquez, E.2
Sanchez-Torres, A.3
-
8
-
-
33847646292
-
Infliximab does not suppress the tuberculin skin test (purified protein derivative
-
Hatemi G, Melikoglu M, Fresko I, Masatlioglu S, Tascilar K, Yazici H (2006) Infliximab does not suppress the tuberculin skin test (purified protein derivative. J Rheumatol 34:474-480
-
(2006)
J Rheumatol
, vol.34
, pp. 474-480
-
-
Hatemi, G.1
Melikoglu, M.2
Fresko, I.3
Masatlioglu, S.4
Tascilar, K.5
Yazici, H.6
-
9
-
-
34547411842
-
Tuberculosis among patients treated with TNF-alpha blockers
-
Fuchs-Polishuk I, Avnon LS, Abu shakra M (2007) Tuberculosis among patients treated with TNF-alpha blockers. Harefuah 146:212-218
-
(2007)
Harefuah
, vol.146
, pp. 212-218
-
-
Fuchs-Polishuk, I.1
Avnon, L.S.2
Abu shakra, M.3
-
10
-
-
34547456898
-
Guidelines of the Israeli association of rheumatology for prevention of tuberculosis in patients treated with TNF-alpha blockers
-
Elkayam O, Balbir-gurman A, Lidgi M, Rahav G, Weiler-Ravel D (2007) Guidelines of the Israeli association of rheumatology for prevention of tuberculosis in patients treated with TNF-alpha blockers. Harefuah 146:235-237
-
(2007)
Harefuah
, vol.146
, pp. 235-237
-
-
Elkayam, O.1
Balbir-gurman, A.2
Lidgi, M.3
Rahav, G.4
Weiler-Ravel, D.5
-
11
-
-
0033769714
-
Does size matter? Utility of size of tuberculin reactions for the diagnosis of mycobacterial disease
-
Al Zahrani K, Al Jahdali H, Menzies D (2000) Does size matter? Utility of size of tuberculin reactions for the diagnosis of mycobacterial disease. Am J Respir Crit Care Med 162:1419-1422
-
(2000)
Am J Respir Crit Care Med
, vol.162
, pp. 1419-1422
-
-
Al Zahrani, K.1
Al Jahdali, H.2
Menzies, D.3
-
12
-
-
1842479974
-
High incidence of anergy in inflammatory bowel disease patients limits the usefulness of PPD screening before infliximab therapy
-
Mow SW, Abreu-martin MT (2004) High incidence of anergy in inflammatory bowel disease patients limits the usefulness of PPD screening before infliximab therapy. Clin Gastroenterol and Hepatol 2:309-313
-
(2004)
Clin Gastroenterol and Hepatol
, vol.2
, pp. 309-313
-
-
Mow, S.W.1
Abreu-martin, M.T.2
-
13
-
-
0036727143
-
A meta-analysis of the effect of Bacille Calmette Guerin vaccination on tuberculin skin test measurement
-
Wang L, Turner MO, Elwood RK et al (2002) A meta-analysis of the effect of Bacille Calmette Guerin vaccination on tuberculin skin test measurement. Thorax 57:804-809
-
(2002)
Thorax
, vol.57
, pp. 804-809
-
-
Wang, L.1
Turner, M.O.2
Elwood, R.K.3
-
14
-
-
0034091974
-
Targeted tuberculin testing and treatment of latent tuberculosis infection
-
American Thoracic Society
-
American Thoracic Society (2000) Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Resp Crit Care Med 161:S221-247
-
(2000)
Am J Resp Crit Care Med
, vol.161
-
-
-
15
-
-
0035136526
-
Increased peripheral T cell reactivity to microbial antigens and collagen type II in rheumatoid arthritis after treatment with soluble TNFalpha receptors
-
Berg L, Lampa J, Rogberg S, van Vollenhoven R, Klareskog L (2001) Increased peripheral T cell reactivity to microbial antigens and collagen type II in rheumatoid arthritis after treatment with soluble TNFalpha receptors. Ann Rheum Dis 60:133-139
-
(2001)
Ann Rheum Dis
, vol.60
, pp. 133-139
-
-
Berg, L.1
Lampa, J.2
Rogberg, S.3
van Vollenhoven, R.4
Klareskog, L.5
-
16
-
-
0344628734
-
High incidence of hepatotoxicity of isoniazid treatment for tuberculosis chemoprophylaxis in patients with rheumatoid arthritis treated with methotrexate or sulfalazine and anti-tumour necrosis factor inhibitors
-
Vanhoof J, Landewe S, Van Wijngaerden Geusens P (2003) High incidence of hepatotoxicity of isoniazid treatment for tuberculosis chemoprophylaxis in patients with rheumatoid arthritis treated with methotrexate or sulfalazine and anti-tumour necrosis factor inhibitors. Ann Rheum Dis 62:1241-1242
-
(2003)
Ann Rheum Dis
, vol.62
, pp. 1241-1242
-
-
Vanhoof, J.1
Landewe, S.2
Van Wijngaerden Geusens, P.3
-
18
-
-
33644643266
-
Guidelines or using the QuantiFERON-TB test for detecting Mycobacterium tuberculosis infection, United States
-
Mazurek G, Jereb J, Lobue P, Iademerco M, Metchock B, Vernon A (2005) Guidelines or using the QuantiFERON-TB test for detecting Mycobacterium tuberculosis infection, United States. MMWR Morb mortal Wkly Recomm Rep 54(RR15):49-55
-
(2005)
MMWR Morb Mortal Wkly Recomm Rep
, vol.54
, Issue.RR15
, pp. 49-55
-
-
Mazurek, G.1
Jereb, J.2
Lobue, P.3
Iademerco, M.4
Metchock, B.5
Vernon, A.6
-
19
-
-
33646026410
-
Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: A prospective study
-
Ferrara G, Losi M, D'Amico R et al (2006) Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: A prospective study. Lancet 367:1328-1334
-
(2006)
Lancet
, vol.367
, pp. 1328-1334
-
-
Ferrara, G.1
Losi, M.2
D'Amico, R.3
-
20
-
-
34447302542
-
Use of QuantiFERON TB Gold test as part of a screening program in patients with RA under consideration for treatment with anti-TNF-alpha agents: The Newcastle experience
-
Pratt A, Nicholl K, Kay L (2007) Use of QuantiFERON TB Gold test as part of a screening program in patients with RA under consideration for treatment with anti-TNF-alpha agents: The Newcastle experience. Rheumatology 46:1035-1036
-
(2007)
Rheumatology
, vol.46
, pp. 1035-1036
-
-
Pratt, A.1
Nicholl, K.2
Kay, L.3
|